Xos Valuation
Is XOS undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of XOS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate XOS's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate XOS's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for XOS?
Key metric: As XOS is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is XOS's PS Ratio? | |
|---|---|
| PS Ratio | 0.6x |
| Sales | US$62.86m |
| Market Cap | US$36.45m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.2x |
| Enterprise Value/EBITDA | -1.8x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does XOS's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.8x | ||
HYZN Hyzon Motors | 1.2x | 97.5% | US$12.9m |
NKLA Nikola | 1.6x | 67.7% | US$123.0m |
CVGI Commercial Vehicle Group | 0.09x | -8.8% | US$78.3m |
MNTX Manitex International | 0.4x | 4.5% | US$117.1m |
XOS Xos | 0.6x | 58.2% | US$36.5m |
Price-To-Sales vs Peers: XOS is good value based on its Price-To-Sales Ratio (0.6x) compared to the peer average (0.8x).
Price to Sales Ratio vs Industry
How does XOS's PS Ratio compare vs other companies in the US Machinery Industry?
Price-To-Sales vs Industry: XOS is good value based on its Price-To-Sales Ratio (0.6x) compared to the US Machinery industry average (1.6x).
Price to Sales Ratio vs Fair Ratio
What is XOS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.6x |
| Fair PS Ratio | 2.2x |
Price-To-Sales vs Fair Ratio: XOS is good value based on its Price-To-Sales Ratio (0.6x) compared to the estimated Fair Price-To-Sales Ratio (2.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$4.54 | US$10.75 +136.8% | 23.1% | US$15.00 | US$9.00 | n/a | 4 |
| Nov ’25 | US$4.39 | US$11.25 +156.3% | 22.1% | US$15.00 | US$9.00 | n/a | 4 |
| Oct ’25 | US$4.49 | US$10.00 +122.7% | 14.1% | US$12.00 | US$9.00 | n/a | 3 |
| Sep ’25 | US$5.02 | US$10.00 +99.2% | 14.1% | US$12.00 | US$9.00 | n/a | 3 |
| Aug ’25 | US$5.97 | US$16.00 +168.0% | 5.1% | US$17.00 | US$15.00 | n/a | 3 |
| Jul ’25 | US$6.80 | US$16.00 +135.3% | 5.1% | US$17.00 | US$15.00 | n/a | 3 |
| Jun ’25 | US$7.94 | US$17.38 +118.8% | 17.7% | US$22.50 | US$15.00 | n/a | 4 |
| May ’25 | US$7.50 | US$17.38 +131.7% | 17.7% | US$22.50 | US$15.00 | n/a | 4 |
| Apr ’25 | US$9.78 | US$17.38 +77.7% | 17.7% | US$22.50 | US$15.00 | n/a | 4 |
| Mar ’25 | US$10.60 | US$16.88 +59.2% | 21.0% | US$22.50 | US$13.00 | n/a | 4 |
| Feb ’25 | US$8.15 | US$19.50 +139.3% | 31.4% | US$30.00 | US$13.00 | n/a | 5 |
| Jan ’25 | US$7.98 | US$43.50 +445.1% | 88.9% | US$120.00 | US$15.00 | n/a | 5 |
| Dec ’24 | US$8.79 | US$43.50 +394.9% | 88.9% | US$120.00 | US$15.00 | n/a | 5 |
| Nov ’24 | US$7.79 | US$60.00 +670.7% | 82.2% | US$120.00 | US$15.00 | US$4.39 | 5 |
| Oct ’24 | US$10.31 | US$51.45 +398.8% | 95.0% | US$120.00 | US$8.70 | US$4.49 | 6 |
| Sep ’24 | US$8.23 | US$51.45 +525.0% | 95.0% | US$120.00 | US$8.70 | US$5.02 | 6 |
| Aug ’24 | US$15.90 | US$54.25 +241.2% | 88.2% | US$120.00 | US$10.50 | US$5.97 | 6 |
| Jul ’24 | US$6.53 | US$54.25 +731.0% | 88.2% | US$120.00 | US$10.50 | US$6.80 | 6 |
| Jun ’24 | US$11.49 | US$54.25 +372.1% | 88.2% | US$120.00 | US$10.50 | US$7.94 | 6 |
| May ’24 | US$15.18 | US$56.00 +268.8% | 82.7% | US$120.00 | US$15.00 | US$7.50 | 6 |
| Apr ’24 | US$15.75 | US$56.00 +255.6% | 82.7% | US$120.00 | US$15.00 | US$9.78 | 6 |
| Mar ’24 | US$21.35 | US$94.50 +342.7% | 57.4% | US$180.00 | US$18.00 | US$10.60 | 6 |
| Feb ’24 | US$29.20 | US$94.50 +223.7% | 57.4% | US$180.00 | US$18.00 | US$8.15 | 6 |
| Jan ’24 | US$13.29 | US$94.50 +611.2% | 57.4% | US$180.00 | US$18.00 | US$7.98 | 6 |
| Dec ’23 | US$18.27 | US$97.50 +433.7% | 51.5% | US$180.00 | US$36.00 | US$8.79 | 6 |
| Nov ’23 | US$34.50 | US$140.00 +305.8% | 61.0% | US$300.00 | US$36.00 | US$7.79 | 6 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
Mitsubishi
JP¥10.3t
Engages in the natural gas, industrial materials and infrastructure, chemicals, mineral resources, automotive and mobility, food and consumer industry, power solution, and urban development businesses worldwide.
MSBH.F
JP¥17.20
7D
-0.8%
1Y
9.5%
NFI Group
CA$1.7b
Manufactures and sells buses in North America, the United Kingdom, rest of Europe, and the Asia Pacific.
NFYE.F
CA$10.45
7D
-4.6%
1Y
1.9%
Doman Building Materials Group
CA$836.2m
Through its subsidiaries, engages in the wholesale distribution of building materials and home renovation products in the United States and Canada.
CWXZ.F
CA$6.86
7D
5.5%
1Y
40.3%